Evidence map›Paper›PMID 24970799›Full record

ArticleOncotarget2014

Post-translational regulation of COX2 activity by FYN in prostate cancer cells.

Anna Alexanian, Bradley Miller, Marla Chesnik, Shama Mirza, Andrey Sorokin

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. RIPK1 ubiquitination regulates its kinase-independent function in development and inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Vanadium Compounds as Pro-Inflammatory Agents: Effects on Cyclooxygenases.International journal of molecular sciences · 2015
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Anna AlexanianDivision of Nephrology and Kidney Disease Center, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Bradley MillerDivision of Nephrology and Kidney Disease Center, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Marla ChesnikDepartment of Biochemistry, Biotechnology and Bioengineering Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Shama MirzaDepartment of Biochemistry, Biotechnology and Bioengineering Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Andrey SorokinDivision of Nephrology and Kidney Disease Center, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Medical College of Wisconsin · US

Funding

Endothelin Signaling and Actions in Renal MesangiumR01DK098159 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI SOROKIN, ANDREY · 2013 to 2016
$1.3M
BK Virus Receptor and polyomavirus nephropathyR21DK088018 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI SOROKIN, ANDREY · 2011 to 2012
$421k
Posttranslational regulation of Cox-2 activityR03CA182114 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI SOROKIN, ANDREY · 2014 to 2015
$153k
NCI NIH HHS R03 CA182114NIDDK NIH HHS R01 DK098159NIDDK NIH HHS R01DK098159NIDDK NIH HHS R21 DK088018
6 · The paper itself

Abstract

While increased COX2 expression and prostaglandin levels are elevated in human cancers, the mechanisms of COX2 regulation at the post-translational level are unknown. Initial observation that COX2 forms adduct with non-receptor tyrosine kinase FYN, prompted us to study FYN-mediated post-translational regulation of COX2. We found that FYN increased COX2 activity in prostate cancer cells DU145, independent of changes in COX2 or COX1 protein expression levels. We report that FYN phosphorylates human COX2 on Tyr 446, and while corresponding phospho-mimetic COX2 mutation promotes COX2 activity, the phosphorylation blocking mutation prevents FYN-mediated increase in COX2 activity.

Indexed as

Cyclooxygenase 2HumansMaleMembrane ProteinsPhosphorylationProstatic NeoplasmsProtein Processing, Post-TranslationalProto-Oncogene Proteins c-fynTransfectionCyclooxygenase 2Membrane ProteinsProto-Oncogene Proteins c-fyn

Identifiers

PMID24970799
PMCPMC4147319
OpenAlexW1517466368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.